AVIR

Atea Pharmaceuticals, Inc. Common Stock

4.04

USD

-0.01

-0.25%

Oct 23, 15:59 UTC -4

Closed

After-Market

4.04

0.00

-0.12%

Atea Pharmaceuticals, Inc. Common Stock (AVIR) Earnings

AVIR Earnings Reports

Positive Surprise Ratio

AVIR beat 17 of 24 last estimates.

71%

Next Report

Date of Next Report

Nov 05, 2026

Estimate for Q3 26 (Revenue/ EPS)

-$0.42

Implied change from Q2 26 (Revenue/ EPS)

+2.44%

Implied change from Q3 25 (Revenue/ EPS)

-20.75%

Atea Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Aug 12, 2026, AVIR reported earnings of -0.41 USD per share (EPS) for Q2 26, beating the estimate of -0.57 USD, resulting in a 28.22% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.20% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.42 USD, with revenue projected to reach -- USD, implying an increase of 2.44% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Tiziana Life Sciences Ltd. Common Shares

Report Date

Oct 16, 2026 For Q2 26

Estimate

-$0.08

Actual

-$0.10

Surprise

-22.55%

argenx SE - ADR

Report Date

Oct 22, 2026 For Q3 26

Estimate

$8.19

Actual

$7.80

Surprise

-4.84%

QIAGEN N.V.

Report Date

Oct 21, 2026 For Q3 26

Estimate

$0.63

Actual

$0.65

Surprise

+2.43%

Nurix Therapeutics, Inc. Common stock

Report Date

Oct 12, 2026 For Q3 26

Estimate

-$0.61

Actual

$4.73

Surprise

+871.74%

FAQ

What were Atea Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Atea Pharmaceuticals, Inc. Common Stock reported EPS of -$0.41, beating estimates by 28.22%, and revenue of $0.00, 0% as expectations.

How did the market react to Atea Pharmaceuticals, Inc. Common Stock's Q2 2026 earnings?

The stock price moved up 0.2%, changed from $5.06 before the earnings release to $5.07 the day after.

When is Atea Pharmaceuticals, Inc. Common Stock expected to report next?

The next earning report is scheduled for Nov 05, 2026.

What are the forecasts for Atea Pharmaceuticals, Inc. Common Stock's next earnings report?

Based on 3 analysts, Atea Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.42 and revenue of -- for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.